Kate has been a consultant paediatric oncologist in the Oxford Children's Hospital since 1995. She has specialised in neuroblastoma and from 2010 to 2016 was the chair of the UK NCRI Children's Cancer and Leukaemia Neuroblastoma group. She has also been the UK representative on the European Neuroblastoma SIOPEN Executive group ( 2013 to 2016). She is a member of the writing committee and Co Principal Investigator of the SIOPEN Low and Intermediate Risk Neuroblastoma Trial, the UK lead paediatric oncologist for the SIOPEN Opsoclonus Myoclonus Study and Chair of the Data Monitoring Committee for the BEACON Trial. Kate joined NBUK as a Medical Trustee in 2013.
Tony has a background in Industry at UK and European Board level. After an initial career in the hospitality industry, Tony moved into the Contracts market with a series of senior Business Development positions across the UK and Ireland. His final role was as European Vice President for Growth for a large US corporation. Upon retirement, he joined Neuroblastoma UK as Fundraising Trustee prior to being elected their Chair in February 2018.
Steve has been a supporter of Neuroblastoma UK since 1996 and a Trustee since 2001, holding a number of portfolios over that period. He has spent most of his career working in healthcare IT and is currently responsible for several NHS IT delivery programmes and services.
Faye joined Neuroblastoma UK as a trustee in 2017 and looks after corporate fundraising partnerships and our internal HR functions. Faye’s background is in business and finance, she is the founding partner of London accountancy firm FUSE and advises businesses on growth, sustainability and corporate responsibility. Faye joined the charity after some personal experience of neuroblastoma and is passionate about making an impact towards finding a cure for neuroblastoma.
Monica joined Neuroblastoma UK in 2017 and is responsible for marketing and communications.
The majority of Alastair's career has been spent working at the forefront of change in acute NHS healthcare, most recently in leading the development and commissioning of specialised services in London and, prior to that, change management in clinical Networks. Alastair came to Neuroblastoma UK in 2017 to front our media presence.
Guy became a Neuroblastoma UK Trustee in 2009, taking on responsibility for our research interests. In 2010 he initiated NBUK’s first biennial Neuroblastoma Research Symposium which has become a well established and respected meeting for UK and European neuroblastoma researchers. Guy was Acting Chair of NBUK during 2017/18 and has now returned to his role as Research Trustee.
Shirley has been a supporter and fundraiser for Neuroblastoma UK since 1996. She became a Trustee in 2006 and is currently Secretary.
Ruby joined Neuroblastoma UK in 2018. Her career spans marketing in various charities, including Shelter and CRUK and she is chair of the IoF Payroll Giving Special Interest Group. Ruby will be taking on responsibility for our fundraising.
Malcolm worked as a qualified corporate treasurer for a number of UK & US corporations including Del Monte and retired from full-time work some years ago. His interests include cooking, playing and teaching bridge and, being born in the Cretaceous period, geology. He has two sons and five grandchildren. Malcolm joined Neuroblastoma UK in 2018.